Interaction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparison

Pharmaceutical Research

Volumn 20, Issue 8, 2003, Pages 1249-1257

  Koning, Gerben A ^a,e   Morselt, Henriëtte W M ^a   Gorter, Arko ^b   Allen, Theresa M ^c   Zalipsky, Samuel ^d   Scherphof, Gerrit L ^a   Kamps, Jan A A M ^a,f  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ALBERTA   (Canada)

^d ALZA CORPORATION   (United States)

^e UTRECHT UNIVERSITY   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Colon cancer; Drug targeting; Immunoliposomes; Kupffer cells; Poly(ethylene glycol); Tumor specific antibody

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G1; IMMUNOLIPOSOME; MONOCLONAL ANTIBODY; POLYINOSINIC ACID; TRITIUM;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CANCER CELL; CELL INTERACTION; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; ISOTOPE LABELING; KUPFFER CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG DELIVERY SYSTEMS; KUPFFER CELLS; LIPOSOMES; MACROPHAGES; MALE; POLYETHYLENE GLYCOLS; RATS; RATS, INBRED STRAINS; RECEPTORS, FC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER;

EID: 0042626531     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025009300562     Document Type: Article

References (30)

1. T. M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau Young. Liposomes containing synthetic lipid derivatives of poly-(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066:29-36 (1991).
2. K. Maruyama, N. Takahashi, T. Tagawa, K. Nagaike, and M. Iwatsuru. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Lett. 413:177-180 (1997).
3. D. Goren, A. T. Horowitz, S. Zalipsky, M. C. Woodle, Y. Yarden, and A. Gabizon. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. Br. J. Cancer 74:1749-1756 (1996).
4. D. B. Kirpotin, J. W. Park, K. Hong, Y. Shao, R. Shalaby, G. Colbern, C. C. Benz, and D. Papahadjopoulos. Targeting of liposomes to solid tumors: The case of sterically stabilized anti-HER2 immunoliposomes. J. Liposome Research 7:391-417 (1997).
5. G. A. Koning, H. W. M. Morselt, A. Gorter, T. M. Allen, S. Zalipsky, J. A. A. M. Kamps, and G. L. Scherphof. Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases. Pharm. Res. 18:1291-1298 (2001).
6. J. A. A. M. Kamps, G. A. Koning, M. J. Velinova, H. W. M. Morselt, M. Wilkens, A. Gorter, J. Donga, and G. L. Scherphof. Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer. J. Drug Target. 8:235-245 (2000).
7. J. A. Harding, C. M. Engbers, M. S. Newman, N. I. Goldstein, and S. Zalipsky. Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. Biochim. Biophys. Acta 1327:181-192 (1997).
8. T. M. Allen, E. Brandeis, C. B. Hansen, G. Y. Kao, and S. Zalipsky. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim. Biophys. Acta 1237:99-108 (1995).
9. K. Maruyama, T. Takizawa, T. Yuda, S. J. Kennel, L. Huang, and M. Iwatsuru. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta 1234:74-80 (1995).
10. A. Mori, S. J. Kennel, M. van Borssum Waalkes, G. L. Scherphof, and L. Huang. Characterization of organ-specific immunoliposomes for delivery of 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine in a mouse lung- metastasis model. Cancer Chemother. Pharmacol. 35:447-456 (1995).
11. S. Zalipsky, C. B. Hansen, D. E. Lopes de Menezes, and T. M. Allen. Long-circulating, polyethylene glycol-grafted immunoliposomes. J. Cotrol. Release 39:153-161 (1996).
12. S. Zalipsky. Synthesis of an end-group functionalized polyethylene glycol- lipid conjugate for preparation of polymer-grafted liposomes. Bioconjug. Chem. 4:296-299 (1993).
13. G. D. Beun, D. H. van Eendenburg, W. E. Corver, C. J. van de Velde, and G. J. Fleuren. T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody. J. Immunother. 11:238-248 (1992).
14. C. J. F. Böttcher, C. M. van Gent, and C. Pries. A rapid and sensitive sub-micro phosphorus determination. Anal. Chim. Acta 24:203-204 (1961).
15. J. T. P. Derksen and G. L. Scherphof. An improved method for the covalent coupling of proteins to liposomes. Biochim. Biophys. Acta 814:151-155 (1985).
16. C. B. Hansen, G. Y. Kao, E. H. Moase, S. Zalipsky, and T. M. Allen. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim. Biophys. Acta 1239:133-144 (1995).
17. G. L. Petterson. A simplification of the protein assay method of lowry et al. which is more generally applicable. Anal. Biochem. 83:346-356 (1977).
18. R. L. Marquet and D. L. Westbroek. and J. Jeekel. Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int. J. Cancer 33:689-692 (1984).
19. J. T. P. Derksen, H. W. M. Morselt, D. Kalicharan, C. E. Hulstaert, and G. L. Scherphof. Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro. Exp. Cell Res. 168:105-115 (1987).
20. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
21. J. A. A. M. Kamps, H. W. M. Morselt, P. J. Swart, D. K. F. Meijer, and G. L. Scherphof. Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. Proc. Natl. Acad. Sci. USA 94:11681-11685 (1997).
22. M. Krieger and J. Herz. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-637 (1994).
23. A. L. Klibanov, K. Maruyama, A. M. Beckerleg, V. P. Torchilin, and L. Huang. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1062:142-148 (1991).
24. G. A. Koning, H. W. M. Morselt, M. J. Velinova, J. Donga, A. Gorter, T. M. Allen, S. Zalipsky, J. A. A. M. Kamps, and G. L. Scherphof. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine (FUdR) from immunoliposomes to colon cancer cells. Biochim. Biophys. Acta 1420:153-167 (1999).
25. 1 and hydrophilic polymers increase liposome circulation times by inhibiting the association of blood proteins. J. Liposome Res. 2:397-410 (1992).
26. D. C. Litzinger, A. M. Buiting, N. van Rooijen, and L. Huang. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta 1190:99-107 (1994).
27. J. Dijkstra, W. J. M. van Galen, and G. L. Scherphof. Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles. Biochim. Biophys. Acta 813:287-297 (1985).
28. D. E. Lopes de Menezes, L. M. Pilarski, and T. M. Allen. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res. 58:3320-3330 (1998).
29. HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. USA 92:1327-1331 (1995).
30. J. W. Park, K. Hong, D. B. Kirpotin, D. Papahadjopoulos, and C. C. Benz. Immunoliposomes for cancer treatment. In J.T. August (ed.), Gene Therapy, Academic Press Inc, San Diego, California, 1997, pp. 399-435.